Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study

Annals of Internal Medicine

Volumn 125, Issue 1, 1996, Pages 26-34

  Gibril, Fathia ^a   Reynolds, James C ^a   Doppman, John L ^a   Chen, Clara C ^a,b   Venzon, David J ^a,c   Termanini, Basel ^a,b   Christian Weber, H ^a,b   Stewart, Charmaine A ^a,b   Jensen, Robert T ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIATRIZOATE; IOPAMIDOL; OCTREOTIDE; PENTETIC ACID; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; GASTRINOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR LOCALIZATION; ZOLLINGER ELLISON SYNDROME;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; BONE AND BONES; FEMALE; GASTRINOMA; HUMANS; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; PROSPECTIVE STUDIES; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ZOLLINGER-ELLISON SYNDROME;

EID: 0030318656     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-1-199607010-00005     Document Type: Article

References (53)

1. Kvols LK. Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors [Editorial). Gastroenterology. 1993;105:1909-14.
2. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-31.
3. Reubi JC Waser B, Horisberger U, Krenning E, Lamberts SW, Gebbers JO, et al. In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood. 1993;82:2143-51.
4. Reubi JC Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol. 1992;43:27-35.
5. Weckbecker G, Raulf F, Stolz B, Bruns C. Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther. 1993;60:245-64.
6. Somatostatin Receptor Imaging for Neuroendocrine Tumors. St. Louis: Mallinckrodt Medical, Inc.: 1994:1.
7. Wolfe MM, Jensen RT. Zollinger-Ellison syndrome. Current concepts in diagnosis and management. N Engl J Med. 1987;317:1200-9.
8. Jensen RT, Gardner JD. Gastrinoma. In: Go VL, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The Pancreas: Biology, Pathobiology, and Disease. 2d ed New York: Raven; 1993:931-78.
9. Doppman JL, Shawker TH, Miller DC. Localization of islet cell tumors. Gastroenterol Clin North Am. 1989;18:793-804.
10. Strader DB, Doppman JL, Orbuch M, Fishbeyn VA, Benya RV, Jensen RT, et al. Functional localization of pancreatic endocrine tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:282-97.
11. Norton JA, Jensen RT. Unresolved surgical issues in the management of patients with the Zollinger-Ellison syndrome. World J Surg. 1991;15:151-9.
12. Orloff SL, Debas HT. Advances in the management of patients with Zollinger-Ellison syndrome. Surg Clin North Am. 1996;75:511-24.
13. Norton JA. Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg. 1994;31:77-156.
14. Nagorney DM, Que FG. Cytoreductive hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:416-30.
15. Azoulay D, Bismuth H. Role of liver surgery and transplantation in patients with hepatic metastases from pancreatic endocrine tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:461-76.
16. Pisegna JR, Doppman JL, Norton JA, Metz DC, Jensen RT. Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci. 1993;38:1318-28.
17. Orbuch M, Doppman JL, Strader DB, Fishbeyn VA, Benya RV, Metz DC, Jensen RT. Imaging for pancreatic endocrine tumor localization: recent advances. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:268-81.
18. de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome, GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. Eur J Nucl Med. 1994;21:1191-7.
19. Norton JA, Sugarbaker PU, Doppman JL, Wesley RA, Maton PN, Gardner JD, et al. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986;203:352-9.
20. Carty SE, Jensen RT, Norton JA. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery. 1992;112:1024-31.
21. Arnold R, Frank M. Systemic chemotherapy for endocrine tumors of the pancreas: recent advances. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:431-8.
22. Barton JC, Hirschowitz BI, Maton PN, Jensen RT. Bone metastases in malignant gastrinoma. Gastroenterology. 1986;91:1179-85.
23. Ellison EH, Wilson SD. The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases. Ann Surg. 1964;160:512-30.
24. Kloppel G, Schroder S, Heitz PU. Histopathology and immunopathology of pancreatic endocrine tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:99-120.
25. Jensen RT. Gastrinoma as a model for prolonged hypergastrinemia in man. In: Walsh JH, ed. Gastrin. New York: Raven; 1993:373-93.
26. Eriksson B, Oberg K, Skogseid B. Neuroendocrine pancreatic endocrine tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol. 1989;28:373-7.
27. Solcia E, Capella C, Fiocca R, Comaggia M, Bosi F. The gastroenteropancreatic endocrine system and related tumors. Gastroenterol Clin North Am. 1989;18:671-93.
28. Fishbeyn VA, Norton JA, Benya RV, Pisegna JR, Venzon DJ, Metz DC, et al. Assessment and prediction of Long-Term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med. 1993;119:199-206.
29. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, et al. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med. 1994;97:436-44.
30. Metz DC, Pisegna JR, Fishbeyn VA, Benya RV, Jensen RT. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J Surg. 1993;17:468-80.
31. Metz DC, Jensen RT. Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:240-57.
32. Sugg SL, Norton JA, Fraker DL, Metz DC Pisegna JR, Fishbeyn V, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg. 1993,218:138-44.
33. London JF, Shawker TH, Doppman JL, Frucht HH, Vinayek R, Stark HA, et al. Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas. Radiology. 1991;178:763-7.
34. Maton PN, Miller DL, Doppman JL, Collen MJ, Norton JA, Vinayek R, et al. Role of selective angiography in the management of Zollinger-Ellison syndrome. Gastroenterology. 1987;92:913-8.
35. Mignon M, Jais P, Cadiot G, Yedder DB, Vatier J. Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:223-39.
36. Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990;323:1246-9.
37. Kvols LK, Brown ML, O'Connor MK, Hung JC, Hayostek RJ, Reubi JC, et al. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology. 1993;187:129-33.
38. 1]-octreotide. Q J Med. 1994;87:83-8.
39. 111In-Pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res. 1993;27(Suppl):28-35.
40. Scherubl H, Bader M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, et al. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology. 1993;105:1705-9.
41. Krenning EP, Kwekkeboom DJ, Oei HY, de Jong RJ, Dop FJ, Reubi JC, et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann N Y Acad Sci. 1994;733:416-24.
42. 1]-octreotide. Acta Oncol. 1993;32:783-6.
43. 111In-Octreotide scintigraphy in oncology. Metabolism. 1992;41:83-6.
44. Zimmer T, Ziegler K, Bader M, Fett U, Hamm B, Riecken EO, et al. Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut. 1994;35:471-5.
45. Weinel RJ, Neuhaus C Stapp J, Klotter HJ, Trautmann ME, Joseph K, et al. Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy. Ann Surg. 1993;218:640-5.
46. Kwekkeboom DJ, Krenning EP, Oei HY, van Eyck CH, Lamberts SW. Use of radiolabeled somatostatin to localize islet cell tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. New York: Karger; 1995:298-308.
47. 111In-octreotide scintigraphy in oncology. Digestion. 1993; 54(Suppl):84-7.
48. 111In-pentatreotide. Clin Endocrinol. 1993;38:501-6.
49. Lamberts SW, Reubi JC, Krenning EP. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors. Acta Oncol. 1993;32:167-70.
50. Corleto VD, Scopinaro F, Angeletti S, Materia A, Basso N, Polettini E, et al. Somatostatin receptor localization of pancreatic endocrine tumors. World J Surg. 1996;20:241-4.
51. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg. 1994;220:320-30
52. Jensen RT, Fraker DL. Zollinger-Ellison syndrome. Advances in treatment of the gastric hypersecretion and the gastrinoma. JAMA 1994;271:1-7.
53. Norton JA. Advances in the management of Zollinger-Ellison syndrome. Adv Surg. 1994;27:129-59.